AI assistant
ACHIEVE LIFE SCIENCES, INC. — Director's Dealing 2022
Jan 5, 2022
33882_dirs_2022-01-05_fd1884f9-354f-4fd3-9d57-3760077c321a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ACHIEVE LIFE SCIENCES, INC. (ACHV)
CIK: 0000949858
Period of Report: 2022-01-03
Reporting Person: Wan Jerry (Principal Accounting Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-01-03 | Performance Restricted Stock Unit (PRSU) | $ | A | 11250 | Acquired | 2026-01-03 | Common Stock (11250) | Direct |
| 2022-01-03 | Stock Option (right to buy) | $8.26 | A | 11250 | Acquired | 2032-01-03 | Common Stock (11250) | Direct |
Footnotes
F1: Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement.
F2: Pursuant to the terms of the PRSU 50% of the total shares underlying the PRSU vest on the achievement of a performance-based milestone, and 50% vest on the first anniversary of the achievement of such milestone. The PRSUs will lapse in full if achievement of such milestone is not met.
F3: The options vest one-third on the first anniversary of January 3, 2022 and thereafter in monthly installments over 24 months.